you are viewing a single comment's thread
view the rest of the comments
[–] 2 points 3 weeks ago

Pharma does this all the time. What's even worse is they will buy the nda/patent and trial it for a completely different application, refile and get a year of exclusivity as the first generic on the market. And the price will skyrocket.

I spent almost two decades working for Tycho, Covidien, Mallinckrodt, GSK/Haleon and several more. The only thing redeeming was the people at the bottom. The rest is just shit all the way up.

  • source